Eisai
4523.T
#1921
Rank
$8.40 B
Marketcap
$29.82
Share price
-0.56%
Change (1 day)
-42.09%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.18

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.18. In 2022 the company made an earnings per share (EPS) of $1.60 a decrease over its 2021 EPS that were of $7.11.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.1836.22%
2022$1.60-77.48%
2021$7.11-41.88%
2020$12.24-0.94%
2019$12.3652.59%
2018$8.10124.17%
2017$3.61-49.42%
2016$7.1437.08%
2015$5.21-11.75%
2014$5.90-3.23%
2013$6.10-18.56%
2012$7.49-15.51%
2011$8.87-3.75%
2010$9.21-1.36%
2009$9.34